ALPS Stock: Alps Group Inc Stock Price, Analysis & Insights
Get live ALPS stock price $0.68, comprehensive Alps Group Inc stock analysis, charts, news, and expert forecast. Real-time ALPS stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge ...
Company Information
- CEO
- Seng Kong Tham
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 2
Contact Information
- Website
- https://alps-holdings.com
- Address
- Unit E-18-01 & E-18-02, Level 18, Icon Tower (East), No. 1, Jalan 1/68F, Off Jalan Tun Razak
- Country
- MY
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -0.12) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Alps Group Inc shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Alps Group Inc
- ⚠Investors should consider how Alps Group Inc fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
113.24M
P/E Ratio (TTM)
-34.02
Beta
-0.12
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare ALPS with peer companies:
- Price
- $0.33-2.98% (1D)
- Market cap
- 42.95M
- Price
- $1.31+11.02% (1D)
- Market cap
- 107.11K
- Price
- $0.36-0.41% (1D)
- Market cap
- 16.85M
- Price
- $0.24+8.11% (1D)
- Market cap
- 69.06K
- Price
- $0.20+3.13% (1D)
- Market cap
- 1.13M
- Price
- $5.01+3.94% (1D)
- Market cap
- 660.80M
- Price
- $0.20+2.45% (1D)
- Market cap
- 8.20M
- Price
- $2.84+7.17% (1D)
- Market cap
- 43.70M
- Price
- $1.49-3.25% (1D)
- Market cap
- 57.17M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
60/100 ⭐⭐⭐⭐
- Overall
- -1.4%
- NYSE
- -0.6%
- NASDAQ
- -2.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.2% | +1.6% | +1.7% | 19.1 | 100/100⭐⭐⭐⭐⭐ |
| Communication Services | -0.2% | -1.8% | +1.2% | 21.9 | 83/100⭐⭐⭐⭐⭐ |
| Energy | -0.2% | -6.1% | +1.5% | 37.0 | 75/100⭐⭐⭐⭐⭐ |
| Healthcare | -1.4% | -3.7% | -0.5% | 30.2 | 60/100⭐⭐⭐⭐ |
| Technology | -0.8% | -7.7% | +0.0% | 48.7 | 55/100⭐⭐⭐⭐ |
| Consumer Defensive | +0.7% | +3.0% | -1.6% | 31.1 | 50/100⭐⭐⭐ |
| Real Estate | -1.0% | -1.8% | -1.9% | 50.3 | 31/100⭐⭐ |
| Industrials | -2.7% | -7.6% | -2.1% | 41.5 | 30/100⭐⭐ |
| Basic Materials | -1.9% | -6.0% | -3.5% | 26.6 | 28/100⭐⭐ |
| Utilities | -2.1% | -6.9% | -8.5% | 25.3 | 24/100⭐ |
| Consumer Cyclical | -1.5% | -4.5% | -3.4% | 52.2 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.